Oligonucleotide Therapeutics Market - Global Outlook and Forecast 2021-2027

Code: RW00014517824
Market Monitor Global
Sep-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Oligonucleotide Therapeutics in Global, including the following market information:
Global Oligonucleotide Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Oligonucleotide Therapeutics market was valued at 3242.9 million in 2020 and is projected to reach US$ 5868.1 million by 2027, at a CAGR of 16.0% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oligonucleotide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oligonucleotide Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Oligonucleotide Therapeutics Market Segment Percentages, By Type, 2020 (%)
Antisense Oligonucleotide
Aptamer
Other

China Oligonucleotide Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Oligonucleotide Therapeutics Market Segment Percentages, By Application, 2020 (%)
Neuromuscular Diseases
ATTR
Hepatic VOD
Other

Global Oligonucleotide Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Oligonucleotide Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Oligonucleotide Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Oligonucleotide Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Oligonucleotide Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oligonucleotide Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oligonucleotide Therapeutics Overall Market Size
2.1 Global Oligonucleotide Therapeutics Market Size: 2021 VS 2027
2.2 Global Oligonucleotide Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oligonucleotide Therapeutics Players in Global Market
3.2 Top Global Oligonucleotide Therapeutics Companies Ranked by Revenue
3.3 Global Oligonucleotide Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Oligonucleotide Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oligonucleotide Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oligonucleotide Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Oligonucleotide Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Oligonucleotide Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oligonucleotide Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Antisense Oligonucleotide
4.1.3 Aptamer
4.1.4 Other
4.2 By Type - Global Oligonucleotide Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Oligonucleotide Therapeutics Revenue, 2016-2021
4.2.2 By Type - Global Oligonucleotide Therapeutics Revenue, 2022-2027
4.2.3 By Type - Global Oligonucleotide Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oligonucleotide Therapeutics Market Size, 2021 & 2027
5.1.2 Neuromuscular Diseases
5.1.3 ATTR
5.1.4 Hepatic VOD
5.1.5 Other
5.2 By Application - Global Oligonucleotide Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Oligonucleotide Therapeutics Revenue, 2016-2021
5.2.2 By Application - Global Oligonucleotide Therapeutics Revenue, 2022-2027
5.2.3 By Application - Global Oligonucleotide Therapeutics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Oligonucleotide Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Oligonucleotide Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Oligonucleotide Therapeutics Revenue, 2016-2021
6.2.2 By Region - Global Oligonucleotide Therapeutics Revenue, 2022-2027
6.2.3 By Region - Global Oligonucleotide Therapeutics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Oligonucleotide Therapeutics Revenue, 2016-2027
6.3.2 US Oligonucleotide Therapeutics Market Size, 2016-2027
6.3.3 Canada Oligonucleotide Therapeutics Market Size, 2016-2027
6.3.4 Mexico Oligonucleotide Therapeutics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Oligonucleotide Therapeutics Revenue, 2016-2027
6.4.2 Germany Oligonucleotide Therapeutics Market Size, 2016-2027
6.4.3 France Oligonucleotide Therapeutics Market Size, 2016-2027
6.4.4 U.K. Oligonucleotide Therapeutics Market Size, 2016-2027
6.4.5 Italy Oligonucleotide Therapeutics Market Size, 2016-2027
6.4.6 Russia Oligonucleotide Therapeutics Market Size, 2016-2027
6.4.7 Nordic Countries Oligonucleotide Therapeutics Market Size, 2016-2027
6.4.8 Benelux Oligonucleotide Therapeutics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Oligonucleotide Therapeutics Revenue, 2016-2027
6.5.2 China Oligonucleotide Therapeutics Market Size, 2016-2027
6.5.3 Japan Oligonucleotide Therapeutics Market Size, 2016-2027
6.5.4 South Korea Oligonucleotide Therapeutics Market Size, 2016-2027
6.5.5 Southeast Asia Oligonucleotide Therapeutics Market Size, 2016-2027
6.5.6 India Oligonucleotide Therapeutics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Oligonucleotide Therapeutics Revenue, 2016-2027
6.6.2 Brazil Oligonucleotide Therapeutics Market Size, 2016-2027
6.6.3 Argentina Oligonucleotide Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oligonucleotide Therapeutics Revenue, 2016-2027
6.7.2 Turkey Oligonucleotide Therapeutics Market Size, 2016-2027
6.7.3 Israel Oligonucleotide Therapeutics Market Size, 2016-2027
6.7.4 Saudi Arabia Oligonucleotide Therapeutics Market Size, 2016-2027
6.7.5 UAE Oligonucleotide Therapeutics Market Size, 2016-2027
7 Players Profiles
7.1 Biogen
7.1.1 Biogen Corporate Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Oligonucleotide Therapeutics Major Product Offerings
7.1.4 Biogen Oligonucleotide Therapeutics Revenue in Global (2016-2021)
7.1.5 Biogen Key News
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Corporate Summary
7.2.2 Sarepta Therapeutics Business Overview
7.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Major Product Offerings
7.2.4 Sarepta Therapeutics Oligonucleotide Therapeutics Revenue in Global (2016-2021)
7.2.5 Sarepta Therapeutics Key News
7.3 Jazz Pharmaceuticals
7.3.1 Jazz Pharmaceuticals Corporate Summary
7.3.2 Jazz Pharmaceuticals Business Overview
7.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Major Product Offerings
7.3.4 Jazz Pharmaceuticals Oligonucleotide Therapeutics Revenue in Global (2016-2021)
7.3.5 Jazz Pharmaceuticals Key News
7.4 Bausch & Lomb
7.4.1 Bausch & Lomb Corporate Summary
7.4.2 Bausch & Lomb Business Overview
7.4.3 Bausch & Lomb Oligonucleotide Therapeutics Major Product Offerings
7.4.4 Bausch & Lomb Oligonucleotide Therapeutics Revenue in Global (2016-2021)
7.4.5 Bausch & Lomb Key News
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Corporate Summary
7.5.2 Alnylam Pharmaceuticals Business Overview
7.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Major Product Offerings
7.5.4 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Revenue in Global (2016-2021)
7.5.5 Alnylam Pharmaceuticals Key News
7.6 Dynavax Technologies
7.6.1 Dynavax Technologies Corporate Summary
7.6.2 Dynavax Technologies Business Overview
7.6.3 Dynavax Technologies Oligonucleotide Therapeutics Major Product Offerings
7.6.4 Dynavax Technologies Oligonucleotide Therapeutics Revenue in Global (2016-2021)
7.6.5 Dynavax Technologies Key News
7.7 Kastle therapeutics
7.7.1 Kastle therapeutics Corporate Summary
7.7.2 Kastle therapeutics Business Overview
7.7.3 Kastle therapeutics Oligonucleotide Therapeutics Major Product Offerings
7.4.4 Kastle therapeutics Oligonucleotide Therapeutics Revenue in Global (2016-2021)
7.7.5 Kastle therapeutics Key News
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Corporate Summary
7.8.2 Akcea Therapeutics Business Overview
7.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Major Product Offerings
7.8.4 Akcea Therapeutics Oligonucleotide Therapeutics Revenue in Global (2016-2021)
7.8.5 Akcea Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Oligonucleotide Therapeutics Market Opportunities & Trends in Global Market
Table 2. Oligonucleotide Therapeutics Market Drivers in Global Market
Table 3. Oligonucleotide Therapeutics Market Restraints in Global Market
Table 4. Key Players of Oligonucleotide Therapeutics in Global Market
Table 5. Top Oligonucleotide Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Oligonucleotide Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Oligonucleotide Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Oligonucleotide Therapeutics Product Type
Table 9. List of Global Tier 1 Oligonucleotide Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oligonucleotide Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE